← SynDRA
CLEVIDIPINE
SynDRA canonical compound SYN0024432 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CACNA1S |
|---|
| Mechanism of action | Calcium channel blocker |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- CACNA1C
- CACNA1D
- CACNA1F
- CACNA1S
Mechanisms of action (all sources)
- Calcium channel blocker
- CACNA1C BLOCKER
- Voltage-gated L-type calcium channel blocker
- CACNA1S BLOCKER
- CACNA1D BLOCKER
- CACNA1F BLOCKER
Drug classes
- Calcium Channel Antagonists
- Dihydropyridine Calcium Channel Blocker
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Membrane Transport Modulators
ATC classes
- C08C · SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
Cross-references
Synonyms
- clevelox
- cleviprex
- Clevidipino
- Clevidepine
- Clevidepine butyrate
- H-324/38
- H324/38
- Cleviprex
- Clevidipine butyrate
- Clevelox
- rac-Clevidipine
- H 324/38
- Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate
- Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
- Cleviprex (TN)
- 3-((butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
- METHYL 5-{[(BUTANOYLOXY)METHOXY]CARBONYL}-4-(2,3-DICHLOROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3
- DTXCID7031450
- clevidipinum
- clevipidine
- RefChem:57329
- C08CA16
- Clevidipine-d5
- MFCD00940070
- SR-01000945183
- Clevidipine [USAN:INN]
- UNII-19O2GP3B7Q
- C21H23Cl2NO6
- Clevip rex
- Cleviprex?
- Clevidipine [INN]
- Clevidipine (Standard)
- Cleviprex (Clevidipine)
- CLEVIDIPINE [MI]
- Clevidipine (USAN/INN)
- CLEVIDIPINE [USAN]
- CLEVIDEPINE [VANDF]
- CLEVIDIPINE [VANDF]
Look up CLEVIDIPINE in the interactive SynDRA portal →